OMGA (Omega Therapeutics Corp) Yalpi foyda marjasi

Omega Therapeutics Inc (OMGA) kompaniyasining rasmiy ramzlari

Omega Therapeutics epigenomik dasturlashning ilk bosqichlariga e'tibor qaratadi va sog'liqni saqlash giganti bilan hamkorlik orqali risklarni kamaytiradi. Operatsion yalpi marja ushbu jarayonlar dinamikasini aks ettiradi, bunda 0.00 yangi darajani qayd etmoqda. O'sish RNA terapiyasini kengaytirish uchun bioreaktorlarning robotlashtirilishi hisobiga ta'minlanmoqda, yakuniy muvaffaqiyat esa grantlar hamda DNKni o'zgartirmagan holda gen modifikatsiyasining tasdiqlangan xavfsizligiga asoslangan.

Omega Therapeutics Corp (OMGA) Yalpi foyda bo'yicha rentabellik: 04.07.2022 - 08.03.2025 davri uchun

omegatherapeutics.com (OMGA) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning asosiy tahlili:OMGA - Omega Therapeutics Inc
Omega Therapeutics seriyali mahsuloti

Omega Therapeutics DNA tuzilishini o'zgartirmasdan genlar ekspressiyasini nazorat qilish orqali epigenetik dori vositalarini ishlab chiqishda yetakchilik qilmoqda. Taxminiy yalpi foyda marginining tahlili ushbu innovatsiyalarni ishlab chiqish va ishlab chiqarish bo'yicha bevosita xarajatlar chegirilgandan keyingi foyda ulushini baholash imkonini beradi. Ushbu ko'rsatkichning barqarorligi xarajatlarning samarali boshqarilishini tasdiqlaydi, bu esa marginning qisqarishi xavfini minimallashtiradi va aktiv narxi dinamikasining uzoq muddatli barqarorligini ta'minlaydi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|RNAZ - Yalpi foyda bo'yicha rentabellik|BNGO: Yalpi foyda bo'yicha rentabellik|APDN (Applied DNA Sciences Inc) - Sotuvning yalpi rentabelligi|BLUE (Bluebird Bio) - Yalpi foyda bo'yicha rentabellik|ImmunoPrecise Antibodies Ltd - Yalpi foyda normasi|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik